LifeAssays
®today – May, 2015
”LifeAssays® is a unique Swedish company focused on
veterinary diagnostic products. Based on its in-house
developed and patented technology, the company develop, produce, market and sell instruments and consumables to veterinary clinics in the Nordic area, most of Europe and has recently taken the step on to the US market.
LifeAssays® test for acute phase proteins in dogs (canine
CRP) has been the entry ticket to a fast growing and
profitable market, veterinary diagnostics. To the canine test the company added similar products for cat and horse
recently.
The robust and very simple test system LifeAssays® supplies
makes it possible to test high performing horses “patient side” before competing, a way to make sure that only healthy
horses compete”.
Om LifeAssays
LifeAssays
®–
strategically placed in IDEON Science park
Company founded 2000
Located in Lund, IDEON Science Park
Public company, listed on NGM in Stockholm
All Development, Production, Market and Sales done at
LifeAssays® unique system for near patient testing
–
Magneto Immuno Assays – LifeAssays
®IPR
Strong IP Rights on process and
technology
Platform for Near Patient Testing in
Veterinary- and Human medicine
Focus on Veterinary diagnostics and Acute
Phase Proteins
Instrument and disposable test reagents
for Dog, Cat and Horse
.
The method/instrument Pat.no: US 6, 110, 660
“Procedure for quantitative and qualitative determination of chemical substances, based on molecular recognition and measurement of magnetic permeability.”
Pat.no: US 7, 910, 063 B2
“Drift compensated magnetic permeability detector”
Pat.no: US 2011, 0104659 A1
“Device for biochemical processing and analysis of sample”
The sampling device Pat.no: US 6, 319, 209 B1
“Disposable test vial with sample delivery device for dispensing sample into reagent”
Pat.no: US 2010/0255460 A1
“Device for biochemical processing and analysis of a sample”
The “one-chip computer” Pat.no: US 2009/0061418 A1
Disposable analytical microprocessor device”
LifeAssays
®applications
in veterinary medicine
–
strategic focus for the Company since 2011
Global veterinary diagnostic market expected to reach 4 200
million USD by 2018
Advanced treatments now drives market towards near patient
testing
USA the largest market & Asia Pacific fastest growing
Spending on healthcare for pets 53.300 mUSD in 2011.
“LifeAssays
®shall focus the application of
its patented technology for POC testing on the
veterinary market in general and the pet
LifeAssays
®transfers advanced diagnostics from
the central service laboratory
Veterinary Clinic Test laboratory
Sample taken and sent to external laboratory for
analysis
Answer back to Veterinarian within 24 to
to the local veterinary clinic
LifeAssays® test gives the veterinarian a result within
15 minutes
Veterinary Clinic
15 minutes
Advanced testing in a PoCT setting
–
LifeAssays
®products are true PoCT
Magnetic measurement:
No calibration needed.
Very specific without any
interference. (otherwise very common in methods using “Light”
Robust and reliable:
Species specific antibodies,
All calibrations already on
the supplied chip in the testkit.
All software updates
immediately implemented through the “one chip
LifeAssays Veterinary
– one instrument for multiple parameters
–
–
LifeAssays
®2014 – growth in more than sales
Sales increased more than 60% in SEK
Instruments up more than 300% Reagents up 28% in numbers
Broadened product portfolio Expansion of the Distributor
network
First steps to increase the
production capacity for reagents and instruments
Agreement with Chinese
company on Human diagnostics Key evaluations of all three
LifeAssays
®product portfolio
–
new Products and improved quality to drive sales
New instrument will be launched Q2 – 2015.
User- and production improvements
Consumables (reagents) for
Dog
Cat
Horse
Colour coded regent tubes
aunched Q2 – 2015.
provements
) for
LifeAssays
®have expanded it´s network of
Distributors –
now present on major markets markets
Europe: 30 000 clinics
Target: 25% of all clinics
USA: 40 000 clinics
Target: 20% of all clinics
Japan: 10 000 clinics
Target: 70% of all clinics
40
% Sweden: 300 clinicsLifeAssays
®on the largest market for veterinary
diagnostics, USA
– all ground work done
Innovative Veterinary
solutions, IVS
Direct sales Marketing
Support to Henry Schein
Henry Schein, IVS Partner
150 sales reps and 3 call centres trained during Q1
“Vendor of the week” in April Special focus on Equine Q2
40 000 clinics – 20% LifeAssays® target market
70 000 000 dogs and 85 000 000 cats 844 000 Race horses
44% of the total Veterinary diagnostic market 520 million USD today to 780 million USD in
2018
68% of all house holds have a pet
LifeAssays® distributor in the US
– IVS anticipates increasing sales after Henry Schein training
“Since the first of the year, IVS has been highly dedicated to the training of Henry Schein sales representatives. The Lexington facility, as well as the Ocala, FL facility, have a large interest in horse racing. The recent “Vendor of the Week” offered exposure to the inside sales reps, visiting field reps and veterinarians and interest in equine haptoglobin was generated. Continued focus on training and communication with Henry Schein will be the focus throughout the year. Marketing
strategies are underway to utilize special programs and offerings extended by Henry Schein.
Additionally, IVS has been in discussions with a prominent equine veterinarian and is grooming him to be a key opinion leader in the field”
Karen L Moody,
President at Innovative Veterinary Solutions
LifeAssays
®established in Europe
– Nordic markets the engine in LifeAssays
®sales
Nordic countries
Alere general distributor Direct sales in Sweden for all
LifeAssays® products
Europe ex. Nordic markets
Present in 3 of 5 major market and evaluating channels in UK.
Nordic countries plus Balkan, Austria and Poland
30 000 clinics – 25% LifeAssays® target market 50 000 000 dogs and 55 000 000 cats
Horse racing important
30% of the total Veterinary diagnostic market 520 million USD today to 780 million USD
LifeAssays® in Asia/Pacific
– the fastest growing markets
India, China and South-East
Asia, the largest growth
potential in veterinary
diagnostics
APAC 523 million USD today -
911 million USD in 2018
Companion animals – 214
today - 401 million USD in
2018
APAC – 18% of the veterinary
diagnostics market
Japan – 45% China – 26%
JAPAN
10 500 clinics – 2/3 LifeAssays® target market 13 000 000 dogs and 8 000 000 cats
9% of the total Veterinary diagnostic market 251 million USD today to 409 million USD in
2018
Distributor since January 2015
Registration on-going, all documents submitted May 12 for registration of dog AND cat test Launch plan ready, seminars starting at Swedish
LifeAssays
®Unitemission - Erbjudandet
Emissionen är med företräde för existerande aktieägare
Fulltecknad emission tillför bolaget 15 MSEK före emissionskostnader vilka beräknas till c:a 700 tKr. Vid fullt utnyttjande av de TO som ingår kan bolaget tillföras ytterligare c:a 5 MSEK
Företrädesrätten gäller
Varje aktie ger rät att teckna en (1) Unit
En (1) Unit består av tre (3) aktier) och en (1) Teckningsoption En (1) TO ger rätt att teckna en (1) aktie
Teckningskurs – 0,15 Kr eller 0,05 Kr/aktie Avstämningsdag – 20 maj
LifeAssays
®Unitemission – Vad skall den användas
till?
2015 är det år vi ägnar uteslutande åt försäljning
Utvecklingsavdelningen
Avslutar instrumentutvecklingen
Marknadsstudier till stöd för försäljningsavdelningen Marknads och försäljningsavdelningen
Lansering i Japan
Seminarieverksamhet
Kundutbildning med svenska veterinärer Lansering i Kina
Kundutbildning med svenska veterinärer Marknadsföringsverktyg
USA
Satsning på Hästmarknaden Geografiskt fokus
Europa
LifeAssays
®2015 – the year of Sales
First quarter
sales up 50% in SEK Vs. Q1, 2014
37 new instruments sold and
placed Vs. 21 Q1, 2014
Sales of Reagents up 51% in
number of tests sold
Second quarter
Finalising the registration in
Japan
Focus on Equine market in
US
Scale up of production of new
